El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/132010

Prognostic value of IL-6 in the localized prostatic cancer

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

Resum

AIM: The usefulness of interleukin 6 (IL-6) and its soluble receptor IL-6sR in the prediction of the biochemical recurrence was evaluated in patients with prostate cancer treated with radical prostatectomy. PATIENTS AND METHODS: IL-6 and sIL-6R serum levels were measured in 96 patients with prostate cancer. RESULTS: Using the log-rank test, it was evident that patients with preoperative serum levels of IL-6 higher than 1.2 pg/ml had a significantly increased probability of biochemical recurrence (p=0.031). We also observed that the Gleason score was associated with the risk of progression (p=0.033), but no relation was observed with TNM classification, PSA, % free PSA or sIL-6R. In a multivariate analysis, only IL-6 serum levels remained as a predictor of biochemical recurrence (p=0.040). CONCLUSION: The results presented here demonstrated the usefulness of IL-6 in predicting the biochemical progression of prostate cancer, pointing towards an association between inflammation and the aggressiveness of the tumor.

Matèries (anglès)

Citació

Citació

ALCOVER GARCÍA, Juan, FILELLA PLA, Xavier, LUQUE GÁLVEZ, Ma. pilar, MOLINA, Rafael (molina porto), IZQUIERDO REYES, Laura, AUGÉ FRADERA, Josep maria, ALCARAZ ASENSIO, Antonio. Prognostic value of IL-6 in the localized prostatic cancer. _Anticancer Research_. 2010. Vol. 30, núm. 10, pàgs. 4369-4372. [consulta: 23 de desembre de 2025]. ISSN: 0250-7005. [Disponible a: https://hdl.handle.net/2445/132010]

Exportar metadades

JSON - METS

Compartir registre